MedPath

Paragonix Kidney Vault Receives FDA Approval for Organ Transport

• Paragonix Technologies' Kidney Vault has received FDA approval, enhancing the preservation and transportation of kidneys for transplantation. • The device maintains a consistent hypothermic environment, aiming to improve organ quality and patient outcomes following kidney transplants. • This FDA nod marks a significant advancement in organ preservation technology, potentially increasing the viability of donor kidneys. • The Kidney Vault addresses critical needs in organ transplantation by providing a standardized and controlled method for kidney transport.

Paragonix Technologies has announced that its Kidney Vault has received FDA approval, marking a significant advancement in organ preservation technology. The Kidney Vault is designed to maintain a consistent hypothermic environment for kidneys during transportation, aiming to improve organ quality and patient outcomes following transplantation.
The Kidney Vault offers a standardized and controlled method for kidney transport, addressing critical needs in organ transplantation. By maintaining a stable, hypothermic environment, the device seeks to minimize the risk of damage to the organ during transit, potentially increasing the viability of donor kidneys.
This FDA approval underscores the growing importance of advanced preservation techniques in the field of organ transplantation, where the need for viable organs continues to outstrip supply.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Copan Diagnostics' UriSponge® Receives FDA Clearance for Streamlined Urine Collection

Copan Diagnostics' UriSponge® has received FDA clearance, offering a novel solution for urine collection and transport, enhancing laboratory efficiency.
The UriSponge® system uses a dip-and-close method to transfer urine, reducing steps and improving workflow for uropathogenic bacteria and yeast cultivation.

FDA Approves iBox Algorithm for Predicting Kidney Graft Survival

The iBox algorithm, developed in France, predicts kidney graft survival up to 10 years post-transplantation using 85 pre- and post-transplant parameters.
Validated across multiple European and American centers and clinical trials, iBox helps clinicians tailor treatments by detecting functional decline trajectories early.

FDA Clears Foundation Surgical's Vertiwedge® Intraosseous System for Vertebral Body Replacement

The FDA has granted 510(k) clearance to Foundation Surgical's Vertiwedge® Intraosseous System, a novel device for partial vertebral body replacement in the thoracolumbar spine.
Indicated for use in T1-L5, the device addresses conditions like trauma, fractures, tumors, and degenerative spine disease by restoring vertebral height.

R3 Vascular's MAGNITUDE Scaffold Receives FDA Approval for BTK PAD Trial

The FDA has approved R3 Vascular to begin the ELITE-BTK trial for its MAGNITUDE drug-eluting bioresorbable scaffold, targeting below-the-knee peripheral arterial disease.
The MAGNITUDE scaffold, made from ultra-high molecular weight polylactic acid polymer, is designed to gradually absorb into the tissue while providing structural support.

L&K Biomed's BluEX Lumbar Expandable Cage System Receives FDA Approval

L&K Biomed secured FDA 510(k) clearance for its BluEX Lumbar Expandable Cage System, designed for enhanced bone integration and versatile surgical approaches.
The BluEX system features six cage designs adaptable for anterior, posterior, lateral, ATP, and endoscopic lumbar approaches, offering surgeons greater flexibility.

Paragonix KidneyVault Receives FDA Clearance for Portable Kidney Perfusion

Paragonix Technologies' KidneyVault, a portable hypothermic perfusion system, has received FDA 510(k) clearance to improve donor kidney preservation during transport.
The KidneyVault system integrates digital monitoring with perfusion technology, aiming to expand the donor kidney pool and enhance organ quality for transplantation.

Paragonix Technologies' KidneyVault Receives FDA Clearance for Portable Kidney Perfusion

Paragonix Technologies has received FDA 510(k) clearance for its KidneyVault System, a portable hypothermic perfusion device for donor kidney preservation.
The KidneyVault integrates digital monitoring with perfusion technology, aiming to improve kidney preservation during transport and expand the donor pool.

SpineGuard's PsiFGuard Receives FDA Clearance for Sacroiliac Joint Fusion

SpineGuard's PsiFGuard, a smart drilling device for posterior sacroiliac fusion (PsiF), has received FDA 510(k) clearance for commercial use in the United States.
The PsiFGuard device utilizes SpineGuard's Dynamic Surgical Guidance (DSG®) technology to enhance the accuracy of implant placement in SI joint fusion procedures.

FDA Expands Indication for Linear Health Sciences' Orchid SRV to Include Blood Transfusions

The FDA has granted an expanded indication for Linear Health Sciences' Orchid Safety Release Valve (SRV) to include blood and blood product transfusions.
The Orchid SRV is a sterile, single-use connector designed to reduce IV dislodgement and improve the experience for both patients and clinicians.

FDA Approves Biotronik's Left Bundle Branch Area Pacing System

The FDA has granted approval for Biotronik's Selectra 3D catheter and Solia S lead system for left bundle branch area pacing (LBBAP).
The approval was based on the BIO-CONDUCT trial, which demonstrated a 95.7% implant success rate and a low 1.7% lead-related complication rate.

Reference News

[1]
Paragonix's Kidney Vault receives FDA nod for organ transport - BioWorld
bioworld.com · Oct 29, 2024

Subscribe to BioWorld™ news services.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy